Top Story

Presence of emphysema on CT scans increases lung cancer risk

March 3, 2015

Emphysema identified in low-dose CT scans increases the risk for lung cancer regardless of a patient’s smoking history, according to findings from the International Early Lung Cancer Action Program.

Because of the high mortality rate associated with lung cancer, early detection is considered essential. CMS recently finalized guidance to ensure Medicare coverage of annual lung cancer screening with low-dose CT for high-risk individuals who meet age and smoking history criteria.

Suzanne C. Cannegieter, MD, PhD In the Journals

Data support predictive significance of superficial vein thrombosis

March 2, 2015
Researchers found that a history of superficial vein thrombosis may be predictive of venous and arterial thrombotic events and these findings may play an important role…
FDA NewsDrug Pipeline

FDA grants orphan drug designation to Reolysin for fallopian tube cancer

March 2, 2015
The FDA today granted orphan drug designation to pelareorep for the treatment of fallopian tube cancer, according to a press release from the drug’s…
FDA NewsDrug Pipeline

FDA grants breakthrough status to EBV-CTL for EBV-associated lymphoproliferative disease

March 2, 2015
The FDA today granted breakthrough therapy designation to EBV-CTL for the treatment of patients with rituximab-refractory, Epstein-Barr virus-associated…
Meeting News Coverage

HIV did not affect HCC recurrence or survival after LT

March 2, 2015
Survival and recurrence rates were unaffected by HIV infection among patients who underwent liver transplantation for hepatocellular carcinoma, according to a poster…
More News Headlines »
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
thumbnail for video 4040847621001

MET targeting, PD-L1/PD-1 inhibition highlight recent developments in genitourinary oncology

February 11, 2015
Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, president of Levine Cancer Institute at Carolinas HealthCare System and…
More »
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »